Literature DB >> 33566261

Prospective analysis of progesterone exposure in programmed single thawed euploid embryo transfer cycles and outcomes.

Carly I Hirschberg1, Jennifer K Blakemore2, Elizabeth Fino2, Jamie A Grifo2.   

Abstract

PURPOSE: In the era of personalized medicine and the increased use of frozen embryo transfer (FET), assay of the endometrium's receptivity prior to transfer has gained popularity, especially among patients. However, the optimal timing for single thawed euploid embryo transfers (STEET) in a programmed FET has yet to be determined Mackens et al. (Hum Reprod. 32(11):2234-42, 2017). We sought to examine the outcomes of euploid FETs by length of progesterone (P4) exposure.
METHODS: Prospective cohort study of programmed FETs of single euploid embryos between June 1, 2018, and December, 18, 2018, at our center. Subjects reported the exact start time for initiating progesterone. The transfer time was noted to calculate the primary independent variable, duration of progesterone exposure. Statistical analysis included ANOVA and Spearman's rho correlation, with p < 0.05 considered significant.
RESULTS: Inclusion criteria were met for 253 programmed STEET cycles in the analysis. There was no significant difference in P4 duration when comparing outcome groups (112.8 ± 3.1 ongoing pregnancy (OP), 112.4 ± 4.4 spontaneous abortion (SAB), 111.6 ± 1.7 biochemical pregnancy (BP), 113.9 ± 5.7 no pregnancy (NP), F 1.76, df 3, p = 0.16). An ROC curve assessing the ability of P4 duration to predict ongoing pregnancy (OP) had an area under the curve of 0.467 (p = 0.38).
CONCLUSION: Duration of P4 was not associated with outcome. Of the cycles, 65.6% resulted in ongoing pregnancy with our center's instructions resulting in an average progesterone exposure of 112.8 h, with a range of 98.3-123.7 h. With growing popularity for individualized testing, these results provide evidence for patient counseling of the high likelihood of ongoing pregnancy without personalized testing.

Entities:  

Keywords:  Personalization; Pregnancy outcomes; Progesterone; STEET

Mesh:

Substances:

Year:  2021        PMID: 33566261      PMCID: PMC8079501          DOI: 10.1007/s10815-021-02074-8

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  5 in total

1.  Medicine. Racing forward: the Genomics and Personalized Medicine Act.

Authors:  Sandra Soo-Jin Lee; Ashwin Mudaliar
Journal:  Science       Date:  2009-01-16       Impact factor: 47.728

2.  Endometrial Receptivity Analysis - a tool to increase an implantation rate in assisted reproduction.

Authors:  L Hromadová; I Tokareva; K Veselá; P Trávník; J Veselý
Journal:  Ceska Gynekol       Date:  2019

3.  Does the endometrial receptivity array really provide personalized embryo transfer?

Authors:  Rawad Bassil; Robert Casper; Nivin Samara; Tzu-Bou Hsieh; Eran Barzilay; Raoul Orvieto; Jigal Haas
Journal:  J Assist Reprod Genet       Date:  2018-05-08       Impact factor: 3.412

Review 4.  Progesterone use in assisted reproductive technology.

Authors:  Elena Labarta; Cristina Rodríguez
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2020-06-04       Impact factor: 5.237

5.  The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure.

Authors:  Maria Ruiz-Alonso; David Blesa; Patricia Díaz-Gimeno; Eva Gómez; Manuel Fernández-Sánchez; Francisco Carranza; Joan Carrera; Felip Vilella; Antonio Pellicer; Carlos Simón
Journal:  Fertil Steril       Date:  2013-06-04       Impact factor: 7.329

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.